NeuroMetrix, Inc.

NeuroMetrix, Inc.verified

NURO

Price:

$3.81

Market Cap:

$7.72M

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physician...[Read more]

Industry

Medical - Devices

IPO Date

2004-07-22

Stock Exchange

NASDAQ

Ticker

NURO

The Enterprise Value as of November 2024 (TTM) for NeuroMetrix, Inc. (NURO) is 6.29M

According to NeuroMetrix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.29M. This represents a change of 20.01% compared to the average of 5.24M of the last 4 quarters.

NeuroMetrix, Inc. (NURO) Historical Enterprise Value (quarterly & annually)

How has NURO Enterprise Value performed in the past?

The mean historical Enterprise Value of NeuroMetrix, Inc. over the last ten years is 32.34M. The current 6.29M Enterprise Value has changed 1.84% with respect to the historical average. Over the past ten years (40 quarters), NURO's Enterprise Value was at its highest in in the September 2021 quarter at 449.45M. The Enterprise Value was at its lowest in in the December 2023 quarter at 4.00M.

Quarterly (TTM)
Annual

Average

32.34M

Median

13.12M

Minimum

1.95M

Maximum

117.96M

NeuroMetrix, Inc. (NURO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeuroMetrix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 307.71%

Maximum Annual Enterprise Value = 117.96M

Minimum Annual Increase = -97.54%

Minimum Annual Enterprise Value = 1.95M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20232.26M-66.40%
20226.73M98.30%
20213.39M-28.75%
20204.76M143.74%
20191.95M-97.54%
201879.52M307.71%
201719.50M-45.34%
201635.68M-30.91%
201551.65M-56.22%
2014117.96M-9.04%

NeuroMetrix, Inc. (NURO) Average Enterprise Value

How has NURO Enterprise Value performed in the past?

The current Enterprise Value of NeuroMetrix, Inc. (NURO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

4.13M

5-year avg

3.82M

10-year avg

32.34M

NeuroMetrix, Inc. (NURO) Enterprise Value vs. Peers

How is NURO’s Enterprise Value compared to its peers?

NeuroMetrix, Inc.’s Enterprise Value is greater than Heart Test Laboratories, Inc. (-834267.00), greater than ReShape Lifesciences Inc. (2.13M), less than Inspira Technologies Oxy B.H.N. Ltd. (19.23M), less than OpGen, Inc. (27.92M), greater than Bone Biologics Corporation (372.73K), greater than Nuwellis, Inc. (4.84M), greater than Tivic Health Systems, Inc. (-1899758.00), greater than Talis Biomedical Corporation (-37931750.00), greater than NanoVibronix, Inc. (-452705.00), greater than Bluejay Diagnostics, Inc. (-6409922.00), less than Vivos Therapeutics, Inc. (7.68M), less than ThermoGenesis Holdings, Inc. (6.40M), greater than Sintx Technologies, Inc. (1.80M), greater than Ra Medical Systems, Inc. (-1531031.00),

Build a custom stock screener for NeuroMetrix, Inc. (NURO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroMetrix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroMetrix, Inc. (NURO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroMetrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NeuroMetrix, Inc.'s Enterprise Value?

What is the highest Enterprise Value for NeuroMetrix, Inc. (NURO)?

What is the 3-year average Enterprise Value for NeuroMetrix, Inc. (NURO)?

What is the 5-year average Enterprise Value for NeuroMetrix, Inc. (NURO)?

How does the current Enterprise Value for NeuroMetrix, Inc. (NURO) compare to its historical average?